Antibiotics have been useful in the treatment of H. pylori‐related benign and malignant
gastroduodenal diseases. However, emergence of antibiotic resistance often decreases the …

Helicobacter pylori is a major human pathogen for which increasing antibiotic resistance
constitutes a serious threat to human health. Molecular mechanisms underlying this …

Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …

Helicobacter pylori drug resistance presents a significant challenge to the successful
eradication of this pathogen. To find strategies to improve the eradication efficacy of H …

The prevalence of Helicobacter pylori infection remains significant worldwide and it depends
on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All …

Helicobacter pylori is a human-specific pathogen with a strict tropism for the gastric mucosa.
This bacterium infects around half of the world population and is the main responsible for …

With the rising prevalence of antimicrobial resistance, the eradication rates of Helicobacter
pylori (H. pylori) with standard treatments are decreasing to unacceptable levels (ie,≤ 80%) …

Therapeutic management of Helicobacter pylori (H. pylori) remains an unsolved issue.
Indeed, no therapeutic regimen is able to cure the infection in all treated patients, and in …

Abstract Treatment of Helicobacter pylori (H. pylori) infection is paramount for the
management of prevalent gastrointestinal disorders including peptic ulcer disease and …

Introduction: Helicobacter pylori antibiotic resistance has increased worldwide and multidrug
resistance (MDR), which seriously hampers eradication success of the frequent chronic …